HSBC Holdings’s Veradermics Inc MANE Stock Holding History

HSBC Holdings’s Portfolio MANE Stock Details MANE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$866K	Buy	+6,901	New	+$646K	﹤0.01%	2021

Other funds holding MANE

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

HSBC Holdings's MANE Position: Q2 2026 in Review

HSBC Holdings opened a new position in Veradermics Inc (MANE) in Q2 2026: 6,901 shares worth $866K. The stake represents ﹤0.01% of the portfolio and ranks #2021 among its holdings.

164 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

HSBC Holdings held 6,901 shares of Veradermics Inc worth $866K as of Q2 2026.
Veradermics Inc was a new HSBC Holdings position in Q2 2026.
Veradermics Inc made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2021 holding.
164 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.